ENTRY       D06635                      Drug
NAME        Rilonacept (USAN/INN);
            Arcalyst (TN)
PRODUCT     ARCALYST (Kiniksa Pharmaceuticals (UK))
FORMULA     C9030H13932N2400O2670S74
EXACT_MASS  201080.7512
MOL_WEIGHT  201206.5291
CLASS       Immunological agent
             DG02019  Interleukin inhibitor
REMARK      ATC code: L04AC04
            Product: D06635<US>
EFFICACY    Anti-inflammatory, Antirheumatic
  DISEASE   Cryopyrin-associated periodic syndromes [DS:H00282]
COMMENT     Rilonacept is IL-1 receptor fusion protein consisting of the Fc portion of human IgG1 and the human IL-1 receptor.
TARGET      IL1 [HSA:3552 3553] [KO:K04383 K04519]
  PATHWAY   hsa04010(3552+3553)  MAPK signaling pathway
            hsa04060(3552+3553)  Cytokine-cytokine receptor interaction
            hsa04064(3553)  NF-kappa B signaling pathway
            hsa04620(3553)  Toll-like receptor signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AC Interleukin inhibitors
                 L04AC04 Rilonacept
                  D06635  Rilonacept (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Immunological Agents
              Immunological Agents, Other
               Interleukin Blockers
                Rilonacept
                 D06635  Rilonacept (USAN/INN)
            Drug groups [BR:br08330]
             Immunological agent
              DG02019  Interleukin inhibitor
               D06635  Rilonacept
            Drug classes [BR:br08332]
             Immunological agent
              DG02019  Interleukin inhibitor
               D06635  Rilonacept
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interleukins
                IL1
                 D06635  Rilonacept (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D06635
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D06635
DBLINKS     CAS: 501081-76-1
            PubChem: 47208286
///
